US parents of under-fives clamor for off-label use over Covid vaccine delays

Authorities warn against practice for younger children due to lack of safety and efficacy data.

Photo: Navy Medicine

As news broke recently that the Covid vaccine for children under five would be delayed in the US amid ongoing clinical trials, a call to make the vaccines off-label for use among those children gained force – but officials caution against vaccinating young children without any safety or efficacy data for this age group.

When providers sign an agreement to provide Covid-19 vaccine shots, they also agree not to give the vaccine off-label, or use it for purposes other than what it was approved to do. Read more at the Guardian.

Categories: Freelance Articles

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 207 other subscribers

NBCC Member

%d bloggers like this: